Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−231.34 MHKD
96.31 MHKD
1.68 B
Om MABPHARM LTD
Sektor
VD
Hao Wang
Webbplats
Huvudkvarter
Hong Kong
Employees (FY)
347
Grundat
2015
ISIN
KYG5780F1046
FIGI
BBG00P5G4RJ9
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
